» Articles » PMID: 38004723

Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport During Three Pandemic Waves in Italy

Abstract

We investigated SARS-CoV-2 variants circulating, from November 2020 to March 2022, among military and civilian personnel at an Air Force airport in Italy in order to classify viral isolates in a potential hotspot for virus spread. Positive samples were subjected to Next-Generation Sequencing (NGS) of the whole viral genome and Sanger sequencing of the spike coding region. Phylogenetic analysis classified viral isolates and traced their evolutionary relationships. Clusters were identified using 70% cut-off. Sequencing methods yielded comparable results in terms of variant classification. In 2020 and 2021, we identified several variants, including B.1.258 (4/67), B.1.177 (9/67), Alpha (B.1.1.7, 9/67), Gamma (P.1.1, 4/67), and Delta (4/67). In 2022, only Omicron and its sub-lineage variants were observed (37/67). SARS-CoV-2 isolates were screened to detect naturally occurring resistance in genomic regions, the target of new therapies, comparing them to the Wuhan Hu-1 reference strain. Interestingly, 2/30 non-Omicron isolates carried the G15S 3CLpro substitution responsible for reduced susceptibility to protease inhibitors. On the other hand, Omicron isolates carried unusual substitutions A1803V, D1809N, and A949T on PLpro, and the D216N on 3CLpro. Finally, the P323L substitution on RdRp coding regions was not associated with the mutational pattern related to polymerase inhibitor resistance. This study highlights the importance of continuous genomic surveillance to monitor SARS-CoV-2 evolution in the general population, as well as in restricted communities.

Citing Articles

Prevalence of Enteric Pathogens and Antibiotic Resistance: Results of a Six-Year Active Surveillance Study on Patients Admitted to a Teaching Hospital.

Marascio N, Pavia G, Brescia B, Riillo C, Barreca G, Gallo L Antibiotics (Basel). 2024; 13(8).

PMID: 39200026 PMC: 11350807. DOI: 10.3390/antibiotics13080726.


Surfing the Waves of SARS-CoV-2: Analysis of Viral Genome Variants Using an NGS Survey in Verona, Italy.

Tonon E, Cecchetto R, Diani E, Medaina N, Turri G, Lagni A Microorganisms. 2024; 12(5).

PMID: 38792676 PMC: 11124265. DOI: 10.3390/microorganisms12050846.

References
1.
Lo Presti A, Di Martino A, Ambrosio L, De Sabato L, Knijn A, Vaccari G . Tracking the Selective Pressure Profile and Gene Flow of SARS-CoV-2 Delta Variant in Italy from April to October 2021 and Frequencies of Key Mutations from Three Representative Italian Regions. Microorganisms. 2023; 11(11). PMC: 10673055. DOI: 10.3390/microorganisms11112644. View

2.
Azad G . The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates. Heliyon. 2021; 7(2):e06167. PMC: 7848562. DOI: 10.1016/j.heliyon.2021.e06167. View

3.
Fabiani M, Ramigni M, Gobbetto V, Mateo-Urdiales A, Pezzotti P, Piovesan C . Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021. Euro Surveill. 2021; 26(17). PMC: 8086247. DOI: 10.2807/1560-7917.ES.2021.26.17.2100420. View

4.
Verde P, Marcantonio C, Costantino A, Martina A, Simeoni M, Taffon S . Diagnostic accuracy of a SARS-CoV-2 rapid antigen test among military and civilian personnel of an Air Force airport in central Italy. PLoS One. 2022; 17(11):e0277904. PMC: 9704652. DOI: 10.1371/journal.pone.0277904. View

5.
Guthrie J, Teatero S, Zittermann S, Chen Y, Sullivan A, Rilkoff H . Detection of the novel SARS-CoV-2 European lineage B.1.177 in Ontario, Canada. J Clin Virol Plus. 2022; 1(1):100010. PMC: 8009655. DOI: 10.1016/j.jcvp.2021.100010. View